Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant Help Center Crisis
Powered By

Top 2 search results for "Cyltezo" in Resources. To see all results and access other features, sign up for free.

Posts
Resources
Q&A
People
Groups
Treatments
FDA’s Approval of Cyltezo, a Biosimilar to Humira, May Mean Lower Psoriasis Treatment Costs
... FDA Approves Cyltezo (Adalimumab-adbm) as First Interchangeable Biosimilar With Humira — Boehring Ingelheim FDA Approves Cyltezo as First Interchangeable Biosimilar for Inflammatory Disease — Healio Why Price of Humira Keeps Rising Despite FDA Approval of Generic Competition — The Washington Post Biosimilars — U.S. ...
Posted 11/17/2021
FDA’s Approval of Cyltezo, a Biosimilar to Humira, May Mean Lower Psoriasis Treatment Costs
... FDA Approves Cyltezo (Adalimumab-adbm) as First Interchangeable Biosimilar With Humira — Boehring Ingelheim FDA Approves Cyltezo as First Interchangeable Biosimilar for Inflammatory Disease — Healio Why Price of Humira Keeps Rising Despite FDA Approval of Generic Competition — The Washington Post Biosimilars — U.S. ...
Posted 11/17/2021
Adalimumab for Psoriatic Arthritis: How Does It Help?
... These include: Adalimumab-adbm (Cyltezo) — The only interchangeable biosimilar approved so far Adalimumab-afzb (Abrilada) Adalimumab-atto (Amjevita) Adalimumab-bwwd (Hadlima) Adalimumab-fkjp (Hulio) Adalimumab-adaz (Hyrimoz) Adalimumab-aqvh (Yusimry) Researchers have at least three more biosimilars in the works, offering people with PsA several treatment ...
Adalimumab for Psoriatic Arthritis: How Does It Help?
... These include: Adalimumab-adbm (Cyltezo) — The only interchangeable biosimilar approved so far Adalimumab-afzb (Abrilada) Adalimumab-atto (Amjevita) Adalimumab-bwwd (Hadlima) Adalimumab-fkjp (Hulio) Adalimumab-adaz (Hyrimoz) Adalimumab-aqvh (Yusimry) Researchers have at least three more biosimilars in the works, offering people with PsA several treatment ...